Options Update: Barr Pharm (BRL)
Barr Pharm (BRL)
BRL Volatility Increases As Shares Sell Off 19%
BRL, a global specialty pharmaceutical company, is recently down $9.91 to $39.86 after reporting weak Q1 results.
BRL June option implied volatility of 34 is above its 26-week average of 28, suggesting larger directional risk.
"
About Paul Foster
Paul Foster is a former member of the Chicago Board Options Exchange with 21-years of professional experience in the capital markets, investments, trading, corporate finance, arbitrage, options and mergers & acquisitions. His writing about the options market has appeared in a wide variety of publications.
View Paul Foster's post archive >
